Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by davgroon Nov 10, 2022 7:48pm
183 Views
Post# 35090172

Curaleaf stock is looking attractive, says Beacon

Curaleaf stock is looking attractive, says Beacon
By Jayson MacLean (Cantech Letter)
Published on November 9, 2022
 
US cannabis name Curaleaf delivered a surprise to the upside in its recent earnings report, according to Beacon Securities analyst Russell Stanley, who reviewed the numbers in a client update on Tuesday.

With the update, Stanley reiterated a “Buy” rating on Curaleaf while lowering his target price from C$14.00 to C$12.00 per share, which at press time represented a projected one-year return of 66 per cent. Year-to-date, CURA is currently down about 33 per cent, while over the past six months the stock is about even.

Read full article at link below:

https://www.cantechletter.com/2022/11/curaleaf-stock-is-looking-attractive-says-beacon/
<< Previous
Bullboard Posts
Next >>